Rakovina Therapeutics appoints Professor Petra Hamerlik to its board
Professor Petra Hamerlik, Chair of Translational Neuro-Oncology at the University of Manchester and previously a member of the company’s Scientific Advisory Board, was elected at Rakovina Therapeutics’ 2026 Annual General Meeting.